NASDAQ: EQEquillium Inc Stock Ownership - Who owns Equillium?
Insider buying vs selling
Have Equillium Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christine Zedelmayer | Sr. Vice President and COO | 2025-11-25 | 100 | $0.98 | $98.00Sell |
| Christine Zedelmayer | Sr. Vice President and COO | 2025-11-25 | 7,998 | $0.95 | $7.60kSell |
| Jason A. Keyes | Chief Financial Officer | 2025-01-23 | 10,000 | $0.65 | $6.50kSell |
EQ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EQ insiders and whales buy or sell their stock.
EQ Shareholders
What type of owners hold Equillium Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Adar1 Capital Management LLC | 9.13% | 5,559,988 | $7.45M | Institution |
| Adage Capital Partners GP LLC | 8.75% | 5,329,416 | $7.14M | Institution |
| Decheng Capital LLC | 7.30% | 4,447,308 | $5.96M | Institution |
| Bruce D. Steel | 6.10% | 3,711,995 | $4.97M | Insider |
| Daniel Bradbury | 6.10% | 3,711,995 | $4.97M | Insider |
| Woodline Partners LP | 5.76% | 3,508,771 | $4.70M | Institution |
| Decheng Capital Global Life Sciences Fund IV LP | 5.40% | 3,285,710 | $4.40M | Insider |
| Sa Biocon | 3.80% | 2,316,134 | $3.10M | Insider |
| Balyasny Asset Management LP | 3.29% | 2,003,648 | $2.68M | Institution |
| Stempoint Capital LP | 3.13% | 1,908,935 | $2.56M | Institution |
EQ vs Biotech Stocks
Equillium Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.